The combination of the low immunohistochemical expression of peroxiredoxin 4 and perilipin 2 predicts longer survival in pancreatic ductal adenocarcinoma with peroxiredoxin 4 possibly playing a main role.

Jia Han(Kanazawa Medical University), Sohsuke Yamada(Kanazawa Medical University), Takeru Oyama(Kanazawa Medical University), Tsuyoshi Mukai(Kanazawa Medical University), Masashi Okuro(Kanazawa Medical University), Masaru Sakurai(Kanazawa Medical University), Hidekazu Kitakata(Kanazawa Medical University), T. Itoh(Kanazawa Medical University), Xin Guo(Kanazawa Medical University), Hiroyuki Takamura(Kanazawa Medical University), Akihiro Shioya(Kanazawa Medical University), Masaru Inagaki(Fukuyama Cardiovascular Hospital), Michiyo Higashi(Kagoshima University), Motona Kumagai(Kanazawa Medical University)
PubMed
December 1, 2023
Cited by 6


Related Papers